News
GRAIL, Inc. was spun off from Illumina in 2024 and offers a promising multi-cancer early detection test called Galleri. Click ...
Cancer screening tests — which are available in many different forms — allow doctors to look for cancer before any symptoms appear. Typically, screenings aren’t intended to diagnose cancer.
Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in ...
Israeli startup SpotItEarly is developing a revolutionary at-home cancer screening test that’s part pup, part AI. The test follows a startling rise in early-onset cancers.
Former President Joe Biden last underwent a Prostate-Specific Antigen (PSA) blood test, one of the most common ways to screen for prostate cancer, in 2014 while he was serving as Barack Obama’s ...
In an effort to combat the prevalence of cervical cancer in the United States, the Food and Drug Administration has approved the first ever at-home cervical cancer screening kit. On Friday, May 9 ...
U.K. study: HPV vaccine reduced cervical cancer rates by 87% in women who were vaccinated at 12 and 13 03:48. The maker of an at-home cervical cancer screening test said Friday it has won approval ...
So while Teal’s at-home test may replace your in-office cervical cancer screening, it’s not a one-for-one substitute for routine preventive care visits, she says. How does the Teal Health at ...
The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV. The test will first be available in California in June. At-home cervical cancer screening test gets FDA approval.
According to Guardant, a study shows blood-based cancer screening test detects 83% of people with colorectal cancer with a specificity of 90%. Health Connection. Get connected to a healthier life.
Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...
GRAIL, Inc.'s Galleri test could unlock a $2.4B market with Medicare coverage for MCED tests. Click here to learn about potential GRAL stock growth & investment risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results